- Report
- May 2026
- 180 Pages
United States
From €4302EUR$4,750USD£3,672GBP
- Report
- March 2026
- 107 Pages
Asia Pacific
From €3577EUR$3,950USD£3,053GBP
- Report
- March 2026
- 104 Pages
Europe
From €3577EUR$3,950USD£3,053GBP
- Report
- March 2026
- 80 Pages
Middle East, Africa
From €3124EUR$3,450USD£2,667GBP
- Report
- March 2026
- 88 Pages
North America
From €3124EUR$3,450USD£2,667GBP
- Report
- February 2026
- 94 Pages
Europe
From €3577EUR$3,950USD£3,053GBP
- Report
- February 2026
- 90 Pages
Asia Pacific
From €3577EUR$3,950USD£3,053GBP
- Report
- February 2026
- 76 Pages
Africa, Middle East
From €3124EUR$3,450USD£2,667GBP
- Report
- February 2026
- 84 Pages
North America
From €3124EUR$3,450USD£2,667GBP
- Report
- October 2025
- 90 Pages
Middle East
From €4075EUR$4,500USD£3,478GBP
- Report
- August 2025
- 73 Pages
Africa, Middle East
From €3124EUR$3,450USD£2,667GBP
- Report
- August 2025
- 97 Pages
Asia Pacific
From €3577EUR$3,950USD£3,053GBP
- Report
- August 2025
- 98 Pages
Europe
From €3577EUR$3,950USD£3,053GBP
- Report
- August 2025
- 89 Pages
North America
From €3124EUR$3,450USD£2,667GBP
- Report
- February 2024
- 280 Pages
Global
From €5275EUR$6,029USD£4,350GBP
- Report
- June 2025
- 276 Pages
Global
From €4483EUR$4,950USD£3,826GBP
- Report
- April 2023
- 106 Pages
Global
From €2038EUR$2,250USD£1,739GBP
- Report
- March 2022
- 73 Pages
Global
From €860EUR$950USD£734GBP
- Report
- June 2024
- 41 Pages
Global
From €2263EUR$2,499USD£1,932GBP
- Report
- September 2024
- 100 Pages
Global
From €5389EUR$5,950USD£4,599GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more